Docoh
Loading...

12 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-K
2016 FY
PCSA Processa Pharmaceuticals Inc
24 Sep 17
Annual report
8:00pm
revenue and discounts on equipment and consumables sold. Concentration of Supplier and Customer Risk - During the year ended December 31, 2016, one
10-K
2015 FY
PCSA Processa Pharmaceuticals Inc
18 Jun 17
Annual report
8:00pm
and consumables sold. Concentration of Supplier and Customer Risk - During the year ended December 31, 2015, the Company’s asphalt repair equipment, including
10-K
2014 FY
PCSA Processa Pharmaceuticals Inc
13 Apr 15
Annual report
8:00pm
or losses reported in the statement of operations. Concentration of Supplier and Customer Risk - During the year ended December 31, 2014, the Company’s
10-K
2013 FY
PCSA Processa Pharmaceuticals Inc
26 Mar 14
Annual report
8:00pm
, 2013, nor gains or losses reported in the statement of operations. Concentration of Supplier and Customer Risk - During the year ended December 31
424B3
PCSA Processa Pharmaceuticals Inc
5 Jun 13
Prospectus supplement
8:00pm
, 2013, nor gains or losses reported in the statement of operations. Concentration of Supplier and Customer Risk – During the period ended March 31 … , 2013, the Company’s asphalt repair equipment, including major components, were purchased from a single supplier. During the same period, one customer
S-1/A
PCSA Processa Pharmaceuticals Inc
22 May 13
IPO registration (amended)
8:00pm
. Concentration of Supplier and Customer Risk – During the period ended March 31, 2013, the Company’s asphalt repair equipment, including major … components, were purchased from a single supplier. During the same period, one customer was responsible for 100% of total revenues. Recent Accounting
S-1/A
PCSA Processa Pharmaceuticals Inc
14 May 13
IPO registration (amended)
8:00pm
in the statement of operations. Concentration of Supplier and Customer Risk – During the period ended March 31, 2013, the Company’s asphalt repair … equipment, including major components, were purchased from a single supplier. During the same period, one customer was responsible for 100% of total revenues
S-1/A
PCSA Processa Pharmaceuticals Inc
10 Apr 13
IPO registration (amended)
8:00pm
in the statement of operations. Concentration of Supplier and Customer Risk - During the year ended December 31, 2012, the Company’s asphalt repair equipment
S-1/A
PCSA Processa Pharmaceuticals Inc
13 Mar 13
IPO registration (amended)
8:00pm
. Concentration of Supplier and Customer Risk – During the year ended December 31, 2012, the Company’s asphalt repair equipment, including major components, were
S-1/A
PCSA Processa Pharmaceuticals Inc
10 Jan 13
IPO registration (amended)
7:00pm
to identify this sole supplier. Please refer to Regulation S-K, Item 101(h)(4)(vi). We have provided the information relating to our supplier
S-1
EX-10
PCSA Processa Pharmaceuticals Inc
13 Nov 12
IPO registration
7:00pm
with the Company or its Affiliates has been terminated or (iii) induce or attempt to induce any customer, supplier or other business relation of the Company … , supplier or business relation, on the one hand, and the Company or its Affiliates, on the other hand. (e) During the Non-Compete Period, you agree
S-1
EX-10
PCSA Processa Pharmaceuticals Inc
13 Nov 12
IPO registration
7:00pm
of Directors, directly or indirectly competes with the Company or (ii) any customer, distributor or supplier of the Company, if the Company’s Board of Directors … should determine that such transfer would result in such customer, distributor or supplier receiving information that would place the Company
  • 1